Greenstone Strikes Sildenafil Deal
Viagra Authorized Generic Offered Via Roman Digital Healthcare Clinic
Pfizer’s Greenstone subsidiary has struck a deal with digital healthcare clinic Roman to offer members access to its authorized generic version of Viagra.
You may also be interested in...
Pfizer To Merge Off-Patent Business With Mylan
Pfizer has announced plans to merge its off-patent unit with Mylan, creating a new generics and biosimilars giant in the US.
Pfizer competes on US Viagra
Pfizer is taking steps to compete with Teva’s recently-launched generic rival to Viagra (sildenafil) in the US, both through the introduction of its own authorised generic and through programmes aimed at supporting patients who still wish to use the brand. The originator’s authorised generic – launched through its Greenstone subsidiary (Generics bulletin, 15 December 2017, page 13) – is priced at around US$30-35 per tablet.
Teva offers services to support sildenafil
Teva has accompanied its launch of a US rival to Pfizer’s Viagra (sildenafil) tablets with a range of “wraparound services to improve patient access”. The generic will compete with a brand that had annual US sales of around US$1.4 billion according to Iqvia, as well as an authorised generic that has just been launched by Pfizer.